Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer

Cancer

Volumn 117, Issue 20, 2011, Pages 4724-4731

  Jonnalagadda, Sirisha ^a   Arcinega, Jacqueline ^b   Smith, Cardinale ^b   Wisnivesky, Juan P ^b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

lymph node metastasis; lymph node ratio; nonsmall cell lung cancer; nonsmall cell lung cancer staging; Surveillance, Epidemiology, and End Results database

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REFERENCE DATABASE; REGRESSION ANALYSIS;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; UNITED STATES;

EID: 80053930370     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26093     Document Type: Article

References (27)

1. Wisnivesky JP, Henschke CI, Swanson S, et al. Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg. 2010; 251: 550-554.
2. Fujimoto T, Cassivi S, Yang P, et al. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival. J Thorac Cardiovasc Surg. 2006; 132: 499-506. (Pubitemid 44278877)
3. Luzzi L, Paladini P, Ghiribelli C, et al. Assessing the prognostic value of the extent of mediastinal lymph node infiltration in surgically treated non-small cell lung cancer (NSCLC). Lung Cancer. 2000; 30: 99-105.
4. Kelsey CR, Marks LB, Hollis D, et al. Local recurrence after surgery for early stage lung cancer. Cancer. 2009; 115: 5218-5227.
5. Osaki T, Nagashima A, Yoshimatsu T, Tashima Y, Yasumoto K,. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer. 2004; 43: 151-157. (Pubitemid 38114743)
6. Demir A, Turna A, Kocaturk C, et al. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer. Ann Thorac Surg. 2009; 87: 1014-1022.
7. Sayar A, Turna A, Kilicgun A, Solak O, Urer N, Gurses A,. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung. Eur J Cardiothorac Surg. 2004; 25: 434-438. (Pubitemid 38340583)
8. Yoshino I, Nakanishi R, Osaki T, et al. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases. Chest. 1999; 116: 144-149. (Pubitemid 29340275)
9. Fukui T, Mori S, Yokoi K, Mitsudomi T,. Significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol. 2006; 1: 220-225.
10. Lee JG, Lee CY, Park IK, et al. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. Ann Thorac Surg. 2008; 85: 211-215. (Pubitemid 350265823)
11. Bria E, Milella M, Sperduti I, et al. A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer. Lung Cancer. 2009; 66: 365-371.
12. Berger AC,. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005; 23: 8706-8712. (Pubitemid 46211514)
13. Greenstein A, Litle V, Swanson S, Divino C, Packer S, Wisnivesky J,. Prognostic significance of the number of lymph node metastases in esophageal cancer. J Am Coll Surg. 2008; 206: 239-226.
14. Herr H,. Superiority of ratio based lymph node staging for bladder cancer. J Urol. 2003; 169: 943-945. (Pubitemid 36188130)
15. Lee H-Y, Choi H-J, Park K-J, et al. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol. 2007; 14: 1712-1717. (Pubitemid 46791006)
16. Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol. 2003; 10: 1077-1085. (Pubitemid 40486832)
17. Vinh-Hung V, Verschraegen C, Promish DI, et al. Ratios of involved nodes in early breast cancer. Breast Cancer Res. 2004; 6: R680-R688.
18. Wisnivesky J, Arciniega J, Mhango G, Halm E,. Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer [published online ahead of print December 2, 2010]. Thorax. 2010.
19. Altekruse S, Kosary C, Krapcho M, et al. eds. SEER Cancer Statistics Review, 1975-2010. Bethesda, MD: National Cancer Institute; 2010.
20. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer, 2010.
21. National Comprehensive Cancer Network. The NCCN Practice Guidelines in Oncology: Nonsmall Cell Lung Cancer. Version v.I. 2010. Fort Washington, PA: NCCN; 2010.
22. Arriagada R, Dunant A, Pignon J-P, et al. Long-term results of the international adjuvant lung cancer trial evaluating adjuvant cisplatin-based chemotherapy in resected lung cancer. J Clin Oncol. 2010; 28: 35-42.
23. PORT Meta-Analysis Trialists Group. Postoperative radiation therapy for non-small cell lung cancer. Cochrane Database Syst Rev. 2005; 2: CD002142.
24. Lally BE,. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the Surveillance, Epidemiology, and End Results database. J Clin Oncol. 2006; 24: 2998-3006. (Pubitemid 46638932)
25. Marra A, Hillejan L, Zaboura G, Fujimoto T, Greschuchna D, Stamatis G,. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. J Thorac Cardiovasc Surg. 2003; 125: 543-553. (Pubitemid 36373900)
26. Ueda K, Kaneda Y, Sakano H, et al. Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer. Jpn J Thorac Cardiovasc Surg. 2003; 51: 297-301. (Pubitemid 38166265)
27. Percy C, Stanek E, 3rd, Gloeckler L,. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health. 1981; 71: 242-250. (Pubitemid 11146407)